Skip to main content
SpringerLink
Log in
Book cover

Hughes Syndrome pp 86–98Cite as

Skin Manifestations of Antiphospholipid Syndrome

  • Chapter

Conclusion

aPL are strongly related to thrombotic events. It is the most common acquired coagulation defect among the ones accountable for procoagulant states.

Skin involvement might be the first manifestation of APS (41%) and over one third of these patients will develop multisystem thrombotic events during the course of the disease. Therefore, a close monitoring of these patients is warranted.

Keywords

  • Systemic Lupus Erythematosus
  • Pyoderma Gangrenosum
  • Skin Manifestation
  • Livedo Reticularis
  • Hughes Syndrome

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (Canada)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Battagliotti CA. Sindrome de anticuerpos antifosfolipidicos. In: Battagliotti CA, Greca A, et al, eds. Temas relacionados de terapeutica clinica. Rosario: UNR Editora; 1996:328–334.

    Google Scholar 

  2. Alegre VA, Gastineau DA, Winkelmann RK. Skin lesions associated with circulating lupus anticoagulant. Br J Dermatol 1989;120:419–429.

    PubMed  CAS  Google Scholar 

  3. Gibson GE, Su WP, Pittelkow MR. Antiphospholipid syndrome and the skin. J Am Acad Dermatol 1997;36:970–982.

    PubMed  CAS  Google Scholar 

  4. Tajima C, Suzuki Y, Mizushima Y, Ichikawa Y. Clinical significance of immunoglobulin A antiphospholipid antibodies: possible association with skin manifestations and small vessel vasculitis. J Rheumatol 1998;25:1730–1736.

    PubMed  CAS  Google Scholar 

  5. Eng AM. Cutaneous expressions of antiphospholipid syndromes. Semin Thromb Hemost 1994;20:71–78.

    PubMed  CAS  Google Scholar 

  6. Naldi L, Locati F, Marchesi L, et al. Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study. Ann Rheum Dis 1993;52:219–222.

    PubMed  CAS  Google Scholar 

  7. Asherson RA, Mayou SC, Merry P, Black MM, Hughes GR. The spectrum of livedo reticularis and anticardiolipin antibodies. Br J Dermatol 1989;120:215–221.

    CrossRef  PubMed  CAS  Google Scholar 

  8. Weinstein C, Miller MH, Axtens R, Buchanan R, Littlejohn GO. Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus. Arch Dermatol 1987;123:596–600.

    CrossRef  PubMed  CAS  Google Scholar 

  9. Niang S, Frances C, Barete S, et al. Dermatologic manifestations of the antiphospholipid syndrome [abstract]. Arthritis Rheum 2003;48:S879.

    Google Scholar 

  10. Sneddon IB. Cerebro-vascular lesions and livedo reticularis. Br J Dermatol 1965;77:180–185.

    PubMed  CAS  Google Scholar 

  11. Martinez Hernandez PL, Lopez Guzman A, Espinosa Arranz E, Monereo Alonso A, Arnalich Fernandez F. Sindrome de Sneddon: valor diagnostico de los anticuerpos antifosfolipidicos. Rev Clin Esp 1991;189:272–274.

    PubMed  CAS  Google Scholar 

  12. Tourbah A, Piette JC, Iba-Zizen MT, Lyon-Caen O, Godeau P, Frances C. The natural course of cerebral lesions in Sneddon syndrome. Arch Neurol 1997;54:53–60.

    PubMed  CAS  Google Scholar 

  13. Stephens CJ. Sneddon’s syndrome. Clin Exp Rheumatol 1992;10:489–492.

    PubMed  CAS  Google Scholar 

  14. Macario F, Macario MC, Ferro A, Goncalves F, Campos M, Marques A. Sneddon’s syndrome: a vascular systemic disease with kidney involvement? Nephron 1997;75:94–97.

    CrossRef  PubMed  CAS  Google Scholar 

  15. Ohtani H, Imai H, Yasuda T, et al. A combination of livedo racemosa, occlusion of cerebral blood vessels, and nephropathy: kidney involvement in Sneddon’s syndrome. Am J Kidney Dis 1995;26:511–515.

    PubMed  CAS  Google Scholar 

  16. Grattan CE, Burton JL. Antiphospholipid syndrome and cutaneous vasoocclusive disorders. Semin Dermatol 1991;10:152–159.

    PubMed  CAS  Google Scholar 

  17. Reyes E, Alarcon-Segovia D. Leg ulcers in the primary antiphospholipid syndrome. Report of a case with a peculiar proliferative small vessel vasculopathy. Clin Exp Rheumatol 1991;9:63–66.

    PubMed  CAS  Google Scholar 

  18. Grob JJ, Bonerandi JJ. Cutaneous manifestations associated with the presence of the lupus anticoagulant. A report of two cases and a review of the literature. J Am Acad Dermatol 1986;15:211–219.

    CrossRef  PubMed  CAS  Google Scholar 

  19. Schmid MH, Hary C, Marstaller B, Konz B, Wendtner CM. Pyoderma gangrenosum associated with the secondary antiphospholipid syndrome. Eur J Dermatol 1998;8:45–47.

    PubMed  CAS  Google Scholar 

  20. Chacek S, MacGregor-Gooch J, Halabe-Cherem J, Nellen-Hummel H, Quinones-Galvan A. Pyoderma gangrenosum and extensive caval thrombosis associated with the antiphospholipid syndrome — a case report. Angiology 1998;49:157–160.

    PubMed  CAS  Google Scholar 

  21. Bard JW, Winkelmann RK. Livedo vasculitis. Segmental hyalinizing vasculitis of the dermis. Arch Dermatol 1967;96:489–499.

    CrossRef  PubMed  CAS  Google Scholar 

  22. Leroux B, Baron E, Garrido G, Alonso A, Bergero A, Fernandez-Bussy R. Vasculitis livedoide: nuestra experiencia. Dermatol Argent 1998;2:121–126.

    Google Scholar 

  23. Winkelmann RK, Schroeter AL, Kierland RR, Ryan TM. Clinical studies of livedoid vasculitis: (segmental hyalinizing vasculitis). Mayo Clin Proc 1974;49:746–750.

    PubMed  CAS  Google Scholar 

  24. Kern AB. Atrophie blanche. Report of two patients treated with aspirin and dipyridamole. J Am Acad Dermatol 1982;6:1048–1053.

    PubMed  CAS  Google Scholar 

  25. Stephansson EA, Niemi KM, Jouhikainen T, Vaarala O, Palosuo T. Lupus anticoagulant and the skin. A longterm follow-up study of SLE patients with special reference to histopathological findings. Acta Derm Venereol 1991;71:416–422.

    PubMed  CAS  Google Scholar 

  26. Hassan ML, Di Fabio NA, Martinez Aquino E, Schroh R, Kien C, Magnin PH. Vasculitis livedoide. Estudio clinico, histopatologico y laboratorial de 10 casos. Rev Arg Dermatol 1987;68:311–319.

    Google Scholar 

  27. Hughes GR. The Prosser-White oration 1983. Connective tissue disease and the skin. Clin Exp Dermatol 1984;9:535–544.

    CrossRef  PubMed  CAS  Google Scholar 

  28. Paira S, Roverano S, Zunino A, Oliva ME, Bertolaccini ML. Extensive cutaneous necrosis associated with anticardiolipin antibodies. J Rheumatol 1999;26:1197–1200.

    PubMed  CAS  Google Scholar 

  29. Dodd HJ, Sarkany I, O’Shaughnessy D. Widespread cutaneous necrosis associated with the lupus anticoagulant. Clin Exp Dermatol 1985;10:581–586.

    CrossRef  PubMed  CAS  Google Scholar 

  30. Asherson RA, Jacobelli S, Rosenberg H, McKee P, Hughes GR. Skin nodules and macules resembling vasculitis in the antiphospholipid syndrome — a report of two cases. Clin Exp Dermatol 1992;17:266–269.

    CrossRef  PubMed  CAS  Google Scholar 

  31. Frances C, Piette JC, Saada V, et al. Multiple subungual splinter hemorrhages in the antiphospholipid syndrome: a report of five cases and review of the literature. Lupus 1994;3:123–128.

    PubMed  CAS  Google Scholar 

  32. Frances C, Piette JC. Antiphospholipid antibody syndrome (Hughes’ syndrome). Dermatol Ther 2001;14:117–125.

    CrossRef  Google Scholar 

  33. Hodak E, Feuerman H, Molad Y, Monselise Y, David M. Primary anetoderma: a cutaneous sign of antiphospholipid antibodies. Lupus 2003;12:564–568.

    CrossRef  PubMed  CAS  Google Scholar 

  34. Disdier P, Harle JR, Andrac L, et al. Primary anetoderma associated with the antiphospholipid syndrome. J Am Acad Dermatol 1994;30:133–134.

    CrossRef  PubMed  CAS  Google Scholar 

  35. Stephansson EA, Niemi KM. Antiphospholipid antibodies and anetoderma: are they associated? Dermatology 1995;191:204–209.

    CrossRef  PubMed  CAS  Google Scholar 

  36. Alegre VA, Winkelmann RK. Histopathologic and immunofluorescence study of skin lesions associated with circulating lupus anticoagulant. J Am Acad Dermatol 1988;19:117–124.

    PubMed  CAS  Google Scholar 

  37. Martinovic Z, Perisic K, Pejnovic N, Lukacevic S, Rabrenovic L, Petrovic M. Antiphospholipid antibodies in inflammatory bowel diseases. Vojnosanit Pregl 1998;55:47–49.

    PubMed  CAS  Google Scholar 

  38. Mevorach D, Goldberg Y, Gomori JM, Rachmilewitz D. Antiphospholipid syndrome manifested by ischemic stroke in a patient with Crohn’s disease. J Clin Gastroenterol 1996;22:141–143.

    CrossRef  PubMed  CAS  Google Scholar 

  39. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998;77:195–207.

    CrossRef  PubMed  CAS  Google Scholar 

  40. Lockshin MD. Which patients with antiphospholipid antibody should be treated and how? Rheum Dis Clin North Am 1993;19:235–247.

    PubMed  CAS  Google Scholar 

  41. Derksen RH, de Groot PG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 1993;52:689–692.

    CrossRef  PubMed  CAS  Google Scholar 

  42. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993–997.

    CrossRef  PubMed  CAS  Google Scholar 

  43. Curwin J, Jang IK, Fuster V. Expanded use of thrombolytic therapy. Mayo Clin Proc 1992;67:1004–1005.

    PubMed  CAS  Google Scholar 

  44. Gertner E, Lie JT. Systemic therapy with fibrinolytic agents and heparin for recalcitrant nonhealing cutaneous ulcer in the antiphospholipid syndrome. J Rheumatol 1994;21:2159–2161.

    PubMed  CAS  Google Scholar 

  45. Klein KL, Pittelkow MR. Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clin Proc 1992;67:923–933.

    PubMed  CAS  Google Scholar 

  46. Gertner E. Treatment with sildenafil for the healing of refractory skin ulcerations in the antiphospholipid syndrome. Lupus 2003;12:133–135.

    CrossRef  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Therapeutics, National University of Rosario, Rosario, Argentina

    Carlos A. Battagliotti

Authors
  1. Carlos A. Battagliotti
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lupus Research Unit, St Thomas’ Hospital, London, UK

    M. A. Khamashta MD, FRCP, PhD (Deputy Head) (Deputy Head)

Rights and permissions

Reprints and Permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Battagliotti, C.A. (2006). Skin Manifestations of Antiphospholipid Syndrome. In: Khamashta, M.A. (eds) Hughes Syndrome. Springer, London. https://doi.org/10.1007/1-84628-009-5_8

Download citation

  • DOI: https://doi.org/10.1007/1-84628-009-5_8

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-873-2

  • Online ISBN: 978-1-84628-009-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

search

Navigation